These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6318994)

  • 1. Etoposide (VP-16) in the treatment of lung cancer.
    Pedersen AG; Hansen HH
    Cancer Treat Rev; 1983 Dec; 10(4):245-64. PubMed ID: 6318994
    [No Abstract]   [Full Text] [Related]  

  • 2. [A phase II study of oral VP-16 in primary lung cancer].
    Matsui Y; Ohshima S; Kado M; Nakayama M; Shimokata K; Sakai S; Ito F; Chikata E; Hara K; Kanda T
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1801-7. PubMed ID: 2994576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phase II study of etoposide in patients with lung cancer, with special reference to small cell carcinoma].
    Kurita Y; Yokoyama A; Kinameri K; Matsuura N; Sano K
    Nihon Gan Chiryo Gakkai Shi; 1986 Feb; 21(1):108-11. PubMed ID: 3009665
    [No Abstract]   [Full Text] [Related]  

  • 4. VP-16-213 chemotherapy for advanced squamous cell carcinoma and adenocarcinoma of the lung.
    Eagan RT; Ingle JN; Creagan ET; Frytak S; Kvols LK; Rubin J; McMachon RT
    Cancer Treat Rep; 1978 May; 62(5):843-4. PubMed ID: 657168
    [No Abstract]   [Full Text] [Related]  

  • 5. [A phase II study of NK171 (etoposide)].
    Kimura K; Niitani H
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):2011-7. PubMed ID: 2996442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of bronchopulmonary small cell carcinoma with a combination of cyclophosphamide and VP-16].
    González Larriba JL; Ordóñez Gallego A; Díaz Pérez MA; García de Paredes ML; Zamora P; Montero García JM
    Med Clin (Barc); 1984 May; 82(19):836-9. PubMed ID: 6330470
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II clinical trial of weekly administration of VP-16-213 in small cell bronchogenic carcinoma.
    Cohen MH; Broder LE; Fossieck BE; Ihde DC; Minna JD
    Cancer Treat Rep; 1977; 61(3):489-90. PubMed ID: 194694
    [No Abstract]   [Full Text] [Related]  

  • 8. Single-dose etoposide in combination with vincristine and doxorubicin in the treatment of small-cell lung cancer (SCLC).
    Timothy AR; Calman FM; Bateman NT; Farebrother M; Slevin ML; Bellamy D; Rubens RD; Costello J
    Semin Oncol; 1985 Mar; 12(1 Suppl 2):45-7. PubMed ID: 2983435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A phase II study of etoposide (VP-16) injection in primary lung cancer by cooperative study group].
    Kado M; Oshima S; Matsui Y; Shimokata K; Hara K; Kanda T; Shima K; Takenaka S
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):116-21. PubMed ID: 3002282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cis-dichlorodiammineplatinum (II) and VP 16-213 combination chemotherapy for non-small cell lung cancer.
    Goldhirsch A; Joss RA; Cavalli F; Sonntag RW; Brunner KW
    Med Pediatr Oncol; 1981; 9(3):205-8. PubMed ID: 6264280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose etoposide (VP-16) in small-cell lung cancer.
    Greco FA; Johnson DH; Hande KR; Porter LL; Hainsworth JD; Wolff SN
    Semin Oncol; 1985 Mar; 12(1 Suppl 2):42-4. PubMed ID: 2983434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Polychemoradiation treatment of non-small cell lung cancer].
    Linchenko IF; Danil'ian Vm
    Med Radiol (Mosk); 1985 Aug; 30(8):64-9. PubMed ID: 2993782
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination chemotherapy with cisplatin and etoposide in bronchogenic squamous cell carcinoma and adenocarcinoma. A study by the EORTC lung cancer working party (Belgium).
    Longeval E; Klastersky J
    Cancer; 1982 Dec; 50(12):2751-6. PubMed ID: 6890404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of anaplastic carcinoma of the lung with VP 16-213].
    Sanz Ortíz J; Saiz García F
    Med Clin (Barc); 1982 Oct 16-31; 79(7):322-4. PubMed ID: 6294420
    [No Abstract]   [Full Text] [Related]  

  • 15. [Phase II study of VP-16 in patients with primary bronchogenic carcinoma, with special reference to small cell carcinoma--a multi-institutional cooperative study].
    Kanda T; Oka M; Hara K; Koteda T; Ishizaki T; Ikebe A; Nakano M; Iwasaki H; Tsutsumi T; Okuno K
    Nihon Gan Chiryo Gakkai Shi; 1986 Feb; 21(1):12-8. PubMed ID: 3009666
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chemotherapy of lung cancer].
    Dement'eva NP
    Sov Med; 1984; (11):55-61. PubMed ID: 6084308
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment strategies in relation to drug action.
    Muggia FM; McVie G
    NCI Monogr; 1987; (4):129-33. PubMed ID: 2819724
    [No Abstract]   [Full Text] [Related]  

  • 18. Cisplatin, etoposide, and mitomycin in the treatment of non-small cell carcinoma of the lung. A pilot study.
    Davis S; Tonato M; Crinò L; Colozza MA; Lubansky K; Grignani F
    Cancer; 1986 Sep; 58(5):1018-9. PubMed ID: 3015372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of etoposide in previously treated small cell carcinoma of the lung.
    Antman K; Pomfret E; Karp G; Skarin A; Canellos G
    Cancer Treat Rep; 1984 Nov; 68(11):1413-4. PubMed ID: 6094004
    [No Abstract]   [Full Text] [Related]  

  • 20. Etoposide as single agent and in combination chemotherapy of bronchogenic carcinoma.
    Goldhirsch A; Joss R; Cavalli F; Brunner KW
    Cancer Treat Rev; 1982 Jun; 9 Suppl():85-90. PubMed ID: 6290057
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.